Healthcare & Life Sciences
ImmVirX
Australia
aliveseries-a
series-a
Stage
2
Investors
About
ImmVirX develops immunotherapy solutions and biopharmaceutical technologies aimed at treating diseases by modulating the immune system, specializing in engineered immune cell therapies.
Explore ImmVirX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.